Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors
- Name
- Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors
- Accession Number
- DBCAT001704
- Description
Not Available
- Drugs
Drug Drug Description GW 468816 Investigated for use/treatment in tobacco dependence. Lanicemine Lanicemine has been used in trials studying the treatment and basic science of Depression, Major Depressive Disorder, and Treatment Resistant Major Depressive Disorder. CERC-301 Mk 0657 has been used in trials studying the treatment of Major Depressive Disorder. GW-468816 GW-468816 is under investigation in clinical trial NCT00218465 (Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking). - Drugs & Drug Targets
Drug Target Type GW 468816 Glycine receptor subunit alpha-1 target